cannabinolic acid

structure given in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Infections 04/27/2022 - "Multivariate data analysis revealed that cannabichromanon and cannabinolic acid showed a discriminant nature and hence can be incorporated in pharmaceutical dosage forms to alleviate COVID-19 infection."
2.	COVID-19 04/27/2022 - "Multivariate data analysis revealed that cannabichromanon and cannabinolic acid showed a discriminant nature and hence can be incorporated in pharmaceutical dosage forms to alleviate COVID-19 infection."

1.	Dosage Forms (Dosage Form)